Selected Publications

Mooney, L. and McKance-Katz, E. (in press). “Psychopharmacological treatments for substance use disorders.”  Chapter in: McCrady, B.S. and Epstein, E.E. (Eds.) Addictions: A Comprehensive Guidebook, 2nd Ed. Oxford University Press: New York, N.Y.

 

Mooney, L., Cooper, C., London, E., Chudzinsky, J., & Rawson, R. (2015).  “Exercise for substance use disorders.”  Chapter in: N. el-Guebalby et al. (Eds.), Textbook of Addiction Treatment: International Perspectives, Springer-Verlag Italia.

 

Rawson, R., Ling, W., and Mooney, L. (2015).  “Clinical management: methamphetamine.”  Chapter in: Galanter, M., Kleber, H.D., and Brady, K. (Eds.) Textbook of Substance Abuse Treatment, 5th Ed. The American Psychiatric Press.

 

Ling, W., Mooney, L., and Rawson, R. (2013).  Amphetamine-type stimulants.  Chapter in: McCrady, B.S. and Epstein, E.E. (Eds.) Addictions: A Comprehensive Guidebook, 2nd Ed.  Oxford University Press: New York, NY. 

 

Mooney, L.J., Cooper, C., London, E., Chudzynski, J., Dolezal, B., Dickerson, D., DO, Brecht, M.L., Penante, J., & Rawson, R.A. (2014).  Exercise for methamphetamine dependence: rationale, design, and methodology.  Journal of Contemporary Clinical Trials 37(1):139-47. 

 

Dolezal BA, Chudzynski J, Storer TW, Abrazado M, Penate J, Mooney L, Dickerson D, Rawson RA, & Cooper CB (2013).  Eight weeks of exercise training improves fitness measures in methamphetamine-dependent individuals in residential treatment. J Addict Med 7(2): 122-8.

 

Mooney, L.J., Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindbald, R., & Ling, W. (2012).  Cocaine Use Reduction with Buprenorphine (CURB): Rationale, Design, and Methodology.  Journal of Contemporary Clinical Trials.  34(2):196-204.

 

Nielsen S., Hillhouse M., Mooney L., Fahey J, & Ling W. (2012).  Comparing buprenorphine induction experience with heroin and prescription opioid users.  Journal of Substance Abuse Treatment 43(3):285-90.

 

Ling, W., Mooney, L., & Wu, L. (2012). Advances in opioid antagonist treatment for opioid addiction. Psychiatric Clinics of North America 35(2): 297-308.

 

Ling, W., Mooney, L., Zhao M.,  Nielsen, S., Torrington, M., & Miotto, K. (2011).  A selective review and commentary on emerging pharmacotherapies for opioid addiction.   Journal of Substance Abuse and Rehabilitation 2: 181–188.  

 

Ling, W., Mooney, L.J., & Hillhouse, M. (2011). Prescription opioid abuse, pain, and addiction: clinical issues and implications. Drug and Alcohol Review 30:300-5.

 

Gonzales, R., Brecht, M.L., Mooney, L. & Rawson, R. (2011). Prescription and over the counter drug misuse in the California public treatment system.  Journal of Substance Abuse Treatment 40(3): 224-9.

 

Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Ang, A., & Rawson, R.A. (2010).  Anxiety disorders among methamphetamine dependent adults: association with treatment outcomes.  The American Journal on Addictions19(5):385-90.   

 

Shetty, V., Mooney, L., Zigler, CM, Belin, TR, Murphy, D, and Rawson, R. (2010).  Methamphetamine use is associated with increased dental disease. Journal of the American Dental Association 141:307-318.

 

Gonzales, R., Mooney, L., and Rawson, R. (2010).  The methamphetamine problem in the United States.  Annual Review of Public Health 31:6.1-6.14

 

Mooney, L.J., Glasner-Edwards, S., Rawson, R.A., and Ling, W. (2009). “Medical consequences of methamphetamine use.”  Chapter in:  Roll, J.M., Rawson, R., Ling, W., and Shoptaw, S. (Eds.), Methamphetamine Addiction: From Basic Science to Treatment. Guilford Press: New York, NY.

 

Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2009). Psychopathology in methamphetamine dependent adults 3 years after treatment.  Drug and Alcohol Review 29:12-20. 

 

Mooney, L.J., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Hunter, J., Haning, B., Colescott, P, Ling, W., & Rawson, R.A. (2009).  Health conditions in methamphetamine-dependent adults 3 years after treatment.  Journal of Addiction Medicine 3(3):155-163.

 

Glasner-Edwards, S., Marinelli-Casey, P., Gonzales, R., Hillhouse, M., Ang, A., Mooney, L.J., & Rawson, R.A. (2009). Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up.  Journal of Nervous and Mental Disease, 197(4): 225-231.

 

Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008). Clinical course and post-treatment outcomes of methamphetamine dependent adults with psychosis. Journal of Substance Abuse Treatment 35: 445-50.

 

Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008). Identifying methamphetamine users at risk for major depressive disorder: findings from the Methamphetamine Treatment Project at 3-year follow-up. The American Journal on Addictions, 17(2):99-102.

 

Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., Rawson, R.A. and the Methamphetamine Treatment Project Corporate Authors. (2008) Risk factors for suicide attempts in methamphetamine dependent patients. The American Journal on Addictions, 17(1):24-7.

 

Gonzales, R., Marinelli-Casey, P., Hillhouse, M., Hunter, J., Mooney, L.J., Ang, A., &Rawson, R.A. (2008).  Hepatitis A and B infection among methamphetamine dependent users [Letter to the editor].  Journal of Substance Abuse Treatment 35:351-52.

 

Mooney, L. Shrikhande, A., and Gona, S. (2006). “Clonidine detoxification protocol for opioid dependent patients;  Detoxification protocol for alcohol dependence”,  Chapter in: Bernstein, C., Levin, Z., Poag, M., and Rubinstein, M., (Eds.), On Call Psychiatry, Third Ed., Elselvier, Inc.: PA.

 

Shrikhande, A. , Gona, S., Mooney, L. (2006) “Intoxication; Substance Withdrawal” chapters in: Bernstein, C., Levin, Z., Poag, M., and Rubinstein, M., (Eds.), On Call Psychiatry, Third Ed., Elselvier, Inc.: PA.

Phone - 310-267-5419

Print Print | Sitemap
© Larissa Mooney, M.D.